Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30045839HIVENSG00000185624.16protein_codingP4HBNoNo5034P07237
TVIS30045840HIVENSG00000185624.16protein_codingP4HBNoNo5034P07237
TVIS30045841HIVENSG00000185624.16protein_codingP4HBNoNo5034P07237
TVIS30045842HIVENSG00000185624.16protein_codingP4HBNoNo5034P07237
TVIS30045843HIVENSG00000185624.16protein_codingP4HBNoNo5034P07237
TVIS30045844HIVENSG00000185624.16protein_codingP4HBNoNo5034P07237
TVIS30045845HIVENSG00000185624.16protein_codingP4HBNoNo5034P07237
TVIS30045846HIVENSG00000185624.16protein_codingP4HBNoNo5034P07237
TVIS30045847HIVENSG00000185624.16protein_codingP4HBNoNo5034P07237
TVIS30045848HIVENSG00000185624.16protein_codingP4HBNoNo5034P07237
TCGA Plot Options
Drug Information
GeneP4HB
DrugBank IDDB03615
Drug NameRibostamycin
Target IDBE0002467
UniProt IDP07237
Regulation Type
PubMed IDs11741285
CitationsHoribe T, Nagai H, Sakakibara K, Hagiwara Y, Kikuchi M: Ribostamycin inhibits the chaperone activity of protein disulfide isomerase. Biochem Biophys Res Commun. 2001 Dec 21;289(5):967-72.
GroupsApproved; Experimental
Direct Classification4,5-disubstituted 2-deoxystreptamines
SMILES[H][C@@]1(O[C@@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2N)O[C@H](CO)[C@@H](O)[C@H]1O
Pathways
PharmGKB
ChEMBLCHEMBL221572